The S protein of SARS‐CoV‐2 majorly interacts with the host angiotensin‐converting enzyme 2 (ACE2) receptor before entering a cell to initiate the infection, so it was mainly used as the target for vaccine development. This evidence concerns the gene ACE2 and infection.